GILEAD SCIENCES INC
Share · US3755581036 · GILD · 885823 (XNAS)
112,85 USD
06.06.2025 21:44
Current Prices from GILEAD SCIENCES INC
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
GILD
|
USD
|
06.06.2025 21:44
|
112,85 USD
| 110,46 USD
+2,16 %
|
![]() XETRA |
GIS.DE
|
EUR
|
06.06.2025 15:35
|
97,90 EUR
| 97,96 EUR
-0,06 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 2,50 % | 15,29 % | -2,75 % | 21,91 % | 74,39 % | 47,04 % |
Company Profile for GILEAD SCIENCES INC Share
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Invested Funds
The following funds have invested in: GILEAD SCIENCES INC invested:
Fund | Vol. in million 2.978,64 | Percentage (%) 6,99 % |
Fund | Vol. in million 33.162,11 | Percentage (%) 2,30 % |
Fund | Vol. in million 5.736,01 | Percentage (%) 1,50 % |
Fund | Vol. in million 821,63 | Percentage (%) 1,45 % |
Fund | Vol. in million 1.882,90 | Percentage (%) 1,45 % |
Company Data
Name GILEAD SCIENCES INC
Company Gilead Sciences, Inc.
Symbol GILD
Website
https://www.gilead.com
Primary Exchange
NASDAQ

WKN 885823
ISIN US3755581036
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Daniel P. O'Day
Market Capitalization 115 Mrd.
Country United States of America
Currency USD
Employees 17,6 T
Address 333 Lakeside Drive, 94404 Foster City
IPO Date 2000-01-03
Dividends from 'GILEAD SCIENCES INC'
Ex-Date | Dividend per Share |
---|---|
14.03.2025 | 0,79 USD |
13.12.2024 | 0,77 USD |
13.09.2024 | 0,77 USD |
14.06.2024 | 0,77 USD |
14.03.2024 | 0,77 USD |
14.12.2023 | 0,75 USD |
14.09.2023 | 0,75 USD |
14.06.2023 | 0,75 USD |
14.03.2023 | 0,75 USD |
14.12.2022 | 0,73 USD |
Stock Splits
Date | Split |
---|---|
28.01.2013 | 2:1 |
25.06.2007 | 2:1 |
07.09.2004 | 2:1 |
08.03.2002 | 2:1 |
22.02.2001 | 2:1 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | GIS.F |
NASDAQ | GILD |
XETRA | GIS.DE |
More Shares
Investors who GILEAD SCIENCES INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.